Delivery Order SPE2DB22D3016-SPE2DB24FARD2
- Not listed
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the supply of Erythromycin 0.5% eye ointment with a potential value of $1,281.36 and a performance period through March 6, 2024. This delivery order falls under a larger indefinite delivery contract (IDC) awarded to...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Erythromycin 0.5% eye ointment, 3.5 grams, with a ceiling value of $1,017.23 and a performance period through December 26, 2024. The contract is not designated as a set-aside. In addition to this delivery order, AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Erythromycin 0.5% eye ointment. The contract has a firm fixed price of $1,195.95 and a period of performance through May 15, 2025. It is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a $2,745.22 Firm Fixed Price Delivery Order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of Erythromycin 0.5% Eye Ointment 3.5GM, with a performance period through July 11, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Erythromycin 0.5% eye ointment, with a ceiling value of $2,072.22 and a period of performance through April 29, 2025. The contract is not set aside for any specific business category. The award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Erythromycin 0.5% eye ointment, a pharmaceutical product, with a ceiling value of $3,110.58 and a period of performance through January 3, 2025. This is a firm-fixed-price contract with no set-aside designation, indicating open competition....
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company, to provide 4,563,764,320 units of Erythromycin 0.5% eye ointment in 3.5 gram tubes. The contract has a ceiling value of $1,227.68 and a period of performance through February 27, 2024. AmerisourceBergen Drug Corp is the prime contractor and has not been awarded the contract under any set-aside...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 0.5% erythromycin eye ointment. The contract has a potential value of $1,006.20 and a completion date of February 23, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. Amerisourcebergen Drug Corp holds an indefinite delivery contract...
- This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Erythromycin 0.5% eye ointment, with a ceiling value of $2,445.67 and a completion date of June 21, 2024. The contract is a Firm Fixed Price (FFP) Delivery Order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract provides for the delivery of Erythromycin 0.5% eye ointment, 3.5 grams, with a ceiling value of $2,324.16 and a period of performance through January 31, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB24FARD2Delivery Order
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The order is for the supply of Erythromycin 0.5% eye ointment, a pharmaceutical product, with a ceiling value of $1,174.73 and a period of performance through March 29, 2024. The contract does not have a set-aside designation. AmerisourceBergen Drug Corp is the prime contractor on this delivery order and is also the prime contractor on a larger $999,999,999.00 indefinite delivery contract (IDC) awarded by DLA to provide a comprehensive range of pharmaceutical products and medical supplies to support the Department of Defense's military treatment programs and facilities worldwide. This IDC serves as the primary contract vehicle for AmerisourceBergen to deliver these products and services to DLA Troop Support Medical.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 3/28/24 |